National Institute of Neurological Disorders and Stroke; Notice of Closed Meetings, 41975-41976 [2023-13723]
Download as PDF
<![CDATA[
Federal Register / Vol. 88, No. 123 / Wednesday, June 28, 2023 / Notices
Dr.
Joshua Denny AOUTribal@nih.gov, 301–
827–9737. More information is available
at https://allofus.nih.gov/
tribalengagement. The All of Us Tribal
Engagement team may also be reached
by email at AOUTribal@nih.gov, or by
mail at All of Us Research Program,
Division of Engagement and Outreach,
Tribal Engagement, NIH, 6710–B
Rockledge Drive, 4th Floor, Bethesda,
MD 20817.
SUPPLEMENTARY INFORMATION:
FOR FURTHER INFORMATION CONTACT:
I. Background Information
The All of Us Research Program aims
to accelerate health research and
medical breakthroughs to enable an era
of precision medicine for all. All of Us
is committed to ensuring the program
reflects the diversity of the United
States.
In the 21st Century Cures Act (Pub. L.
114–255), Congress authorized NIH to
carry out the Precision Medicine
Initiative, which includes the All of Us
Research Program. The law provides
NIH with critical tools and resources to
advance biomedical research across the
spectrum, from foundational basic
research studies to advanced clinical
trials of promising new therapies, in
part through the establishment of a
diverse cohort of individuals to support
the goals of All of Us.
II. Tribal Virtual Informational
Presentations and Discussions With
Tribal Communities
In June 2023, All of Us held four
information and discussion sessions
virtually to continue to engage with
Tribal Nations and rural and urban AI/
AN communities. Recorded sessions
will be made available at https://
allofus.nih.gov/about/diversity-andinclusion/tribal-engagement.
ddrumheller on DSK120RN23PROD with NOTICES1
III. Questions
A. Management and Sharing of SelfIdentified AI/AN Data (Without Tribal
Affiliation)
1. Integrating information from selfidentified AI/AN participants in our
data platform, the All of Us Research
Hub at https://www.researchallofus.org.
(a) How can the program augment the
current policies and protections for selfidentified AI/AN participant data so
that it can be shared with researchers?
(b) What additional policies or
guidance would you like All of Us to
consider around the use of data from
self-identified AI/AN participants?
2. Honoring Tribal sovereignty when
working with self-identified AI/AN
individuals who consent to participate.
(a) What kinds of protective practices
and measures can be implemented to
VerDate Sep<11>2014
20:02 Jun 27, 2023
Jkt 259001
avoid infringing upon Tribal sovereignty
when collecting or working with
individual participant data?
(b) How should the program manage
and share data from self-identified AI/
AN individuals who choose to
participate in the program, including
those who are living off Tribal lands
and/or who are not affiliated with a
federally recognized Tribe?
B. Tribal Engagement and Outreach
1. Possible future marketing efforts in
zip codes that overlap on Tribal land
and areas bordering Tribal land.
(a) How should the program guide
engagement and outreach efforts where
zip codes overlap with Tribal land?
2. Program activities for individual
participants on Tribal land.
(a) What protocol should be followed
when individual participants request
program materials to be mailed to them
or request home visits on Tribal lands?
C. Program Planning Activities
1. Future inclusion of children in the
All of Us Research Program.
(a) What unique considerations are
there for the future inclusion of AI/AN
infants, children, and adolescents as
participants in the program, given that
a child’s parent or legal guardian must
be a current participant?
(b) What unique considerations are
there for family-based enrollment in the
research program (e.g., parent or legal
guardian participating with their child)?
(c) What specific factors should be
taken into account when enrolling
families in the research program,
considering the possibility of kinship
caregivers or non-traditional child care
arrangements for the child?
2. AI/AN traditional blessing
ceremony for biosamples of participants
who withdraw from the program.
(a) How should the program proceed
in conducting a traditional blessing
ceremony for the participants who selfidentify as AI/AN and request a blessing
ceremony prior to the biosample
disposition?
Dated: June 22, 2023.
Tara A. Schwetz,
Acting Principal Deputy Director, National
Institutes of Health.
[FR Doc. 2023–13750 Filed 6–27–23; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
41975
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; NIH Support for
Conferences and Scientific Meetings (Parent
R13 Clinical Trial Not Allowed).
Date: August 1–2, 2023.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3G11,
Rockville, MD 20892 (Virtual Meeting).
Contact Person: Barry J. Margulies, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, National Institutes of Health, 5601
Fishers Lane, Room 3G11, Rockville, MD
20852, (301) 761–7956, barry.margulies@
nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: June 23, 2023.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–13725 Filed 6–27–23; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Notice of Closed
Meetings
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
Frm 00102
Fmt 4703
Sfmt 4703
E:\FR\FM\28JNN1.SGM
28JNN1
41976
Federal Register / Vol. 88, No. 123 / Wednesday, June 28, 2023 / Notices
ddrumheller on DSK120RN23PROD with NOTICES1
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel; Review of conference grant
applications (R13).
Date: July 18, 2023.
Time: 9:00 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Virtual
Meeting).
Contact Person: Tatiana Pasternak, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Activities,
NINDS/NIH, NSC, 6001 Executive Blvd.,
Suite 3208, MSC 9529, Rockville, MD 20852,
301–496–9223, tatiana.pasternak@nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel; NINDS Summer Research
R25 Review.
Date: July 20, 2023.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Virtual
Meeting).
Contact Person: DeAnna Lynn Adkins,
Ph.D., Scientific Review Officer, Scientific
Review Branch, Division of Extramural
Activities, NINDS/NIH, NSC, 6001 Executive
Blvd., Suite 3208, MSC 9529, Rockville, MD
20852, 301–496–9223, deanna.adkins@
nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS.)
Dated: June 23, 2023.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–13723 Filed 6–27–23; 8:45 am]
BILLING CODE 4140–01–P
VerDate Sep<11>2014
18:48 Jun 27, 2023
Jkt 259001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Eunice Kennedy Shriver National
Institute of Child Health and Human
Development; Notice of Closed
Meetings
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel; Physiomimetics and
Organoids for Reproductive Health (R01
Clinical Trial Not Allowed).
Date: July 14, 2023.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Eunice
Kennedy Shriver National Institute of Child
Health and Human Development, 6710B
Rockledge Drive, Room 2131B, Bethesda, MD
20892 (Virtual Meeting).
Contact Person: Jolanta Maria Topczewska,
Ph.D., Scientific Review Officer, Scientific
Review Branch, Eunice Kennedy Shriver
National Institute of Child Health and
Human Development, National Institutes of
Health, 6710B Rockledge Drive, Room 2131B,
Bethesda, MD 20892, (202) 309–7153,
jolanta.topczewska@nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel; NCMRR Early
Career Research Award (R03 Clinical Trial
Optional).
Date: July 25–26, 2023.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Eunice
Kennedy Shriver National Institute of Child
Health and Human Development, 6710B
Rockledge Drive, 2125D, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Moushumi Paul, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Eunice Kennedy Shriver National
Institute of Child Health and Human
Development, National Institutes of Health,
6710B Rockledge Drive, Room 2125D,
PO 00000
Frm 00103
Fmt 4703
Sfmt 4703
Bethesda, MD 20892, (301) 496–3596,
moushumi.paul@nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.865, Research for Mothers
and Children; 93.929, Center for Medical
Rehabilitation Research, National Institutes
of Health, HHS)
Dated: June 23, 2023.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–13727 Filed 6–27–23; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
U.S. Citizenship and Immigration
Services
[OMB Control Number 1615–0015]
Agency Information Collection
Activities; Revision of a Currently
Approved Collection: Immigrant
Petition for Alien Workers
U.S. Citizenship and
Immigration Services, Department of
Homeland Security.
ACTION: 60-Day notice.
AGENCY:
The Department of Homeland
Security (DHS), U.S. Citizenship and
Immigration Services (USCIS) invites
the general public and other Federal
agencies to comment upon this
proposed revision of a currently
approved collection of information. In
accordance with the Paperwork
Reduction Act (PRA) of 1995, the
information collection notice is
published in the Federal Register to
obtain comments regarding the nature of
the information collection, the
categories of respondents, the estimated
burden (i.e. the time, effort, and
resources used by the respondents to
respond), the estimated cost to the
respondent, and the actual information
collection instruments.
DATES: Comments are encouraged and
will be accepted for 60 days until
August 28, 2023.
ADDRESSES: All submissions received
must include the OMB Control Number
1615–0015 in the body of the letter, the
agency name and Docket ID USCIS–
2007–0018. Submit comments via the
Federal eRulemaking Portal website at
https://www.regulations.gov under eDocket ID number USCIS–2007–0018.
SUMMARY:
E:\FR\FM\28JNN1.SGM
28JNN1
]]>Agencies
[Federal Register Volume 88, Number 123 (Wednesday, June 28, 2023)]
[Notices]
[Pages 41975-41976]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-13723]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Neurological Disorders and Stroke; Notice
of Closed Meetings
Pursuant to section 1009 of the Federal Advisory Committee Act, as
[[Page 41976]]
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Neurological Disorders
and Stroke Special Emphasis Panel; Review of conference grant
applications (R13).
Date: July 18, 2023.
Time: 9:00 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Neuroscience Center, 6001
Executive Boulevard, Rockville, MD 20852 (Virtual Meeting).
Contact Person: Tatiana Pasternak, Ph.D., Scientific Review
Officer, Scientific Review Branch, Division of Extramural
Activities, NINDS/NIH, NSC, 6001 Executive Blvd., Suite 3208, MSC
9529, Rockville, MD 20852, 301-496-9223, [email protected].
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of Neurological Disorders
and Stroke Special Emphasis Panel; NINDS Summer Research R25 Review.
Date: July 20, 2023.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Neuroscience Center, 6001
Executive Boulevard, Rockville, MD 20852 (Virtual Meeting).
Contact Person: DeAnna Lynn Adkins, Ph.D., Scientific Review
Officer, Scientific Review Branch, Division of Extramural
Activities, NINDS/NIH, NSC, 6001 Executive Blvd., Suite 3208, MSC
9529, Rockville, MD 20852, 301-496-9223, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.853,
Clinical Research Related to Neurological Disorders; 93.854,
Biological Basis Research in the Neurosciences, National Institutes
of Health, HHS.)
Dated: June 23, 2023.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-13723 Filed 6-27-23; 8:45 am]
BILLING CODE 4140-01-P
